Live from the NIH registry
Studies recruiting near Worcester right now
Top 25 of 272 recruiting studies, sorted by proximity — each links to its official registry page
Supporting Treatment Access and Recovery in COD
Opioid Use Disorder, Mental Health Disorder
N/A
Interventional 1,000 participants sought
UMass Chan Road to Care Clinic — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
Lupus Landmark Study: A Prospective Registry and Biorepository
Systemic Lupus Erythematosus (SLE), Lupus Nephritis
N/A
Observational 3,500 participants sought
University of Massachusetts Memorial Health — Worcester, Massachusetts (0.6 mi)
· Sponsor: Lupus Research Alliance
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Agitation
Phase 2
Interventional 150 participants sought
Vitalix — Worcester, Massachusetts (0.6 mi)
· Sponsor: Teikoku Pharma USA, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of Massachusetts — Worcester, Massachusetts (0.6 mi)
· Sponsor: Kura Oncology, Inc.
Individualizing Treatment for Asthma in Primary Care (Full Study)
Asthma, Asthma Attack
Phase 4
Interventional 3,200 participants sought
Reliant Medical Group — Worcester, Massachusetts (0.6 mi)
· Sponsor: DARTNet Institute
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: SWOG Cancer Research Network
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional — Milford, Massachusetts (17.4 mi)
· Sponsor: NRG Oncology
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
COVID-19 Infection
Phase 3
Interventional 300 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Pfizer
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
University of Massachusetts Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Eli Lilly and Company
Energy Dense Fueling for Cold-Weather Operations
Cold Exposure
N/A
Interventional 8 participants sought
USARIEM — Natick, Massachusetts (23.5 mi)
· Sponsor: United States Army Research Institute of Environmental Medicine
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
University of Massachusetts Memorial Healthcare — Worcester, Massachusetts (0.6 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
Nectero EAST System Clinical Study
Abdominal Aortic Aneurysm
Phase 2, Phase 3
Interventional 400 participants sought
University of Massachusetts — Worcester, Massachusetts (0.6 mi)
· Sponsor: Nectero Medical, Inc.
Intravenous Iron Effects on Performance at High Altitude
Hypoxia
Phase 4
Interventional 24 participants sought
USARIEM — Natick, Massachusetts (23.5 mi)
· Sponsor: United States Army Research Institute of Environmental Medicine
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
UMass Memorial Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Penumbra Inc.
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
UMass Memorial Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Magenta Medical Ltd.
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Non-small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 614 participants sought
University of Massachusetts Chan Medical School-Division of Hematology/Oncology ( Site 0144) — Worcester, Massachusetts (0.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Framingham, Massachusetts (20.0 mi)
· Sponsor: 89bio, Inc.
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
University of Massachusetts Memorial Health Care — Worcester, Massachusetts (0.6 mi)
· Sponsor: Nicole Hamblett
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
COPD (Chronic Obstructive Pulmonary Disease)
N/A
Interventional 50 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
Skilled Nursing Facility at Home Trial
Skilled Nursing Facility, Rehabilitation
N/A
Interventional 650 participants sought
UMass Memorial Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Phase 3
Interventional 200 participants sought
New England Regional Headache Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Pfizer
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
Essential Thrombocythemia
Phase 3
Interventional 426 participants sought
University of Massachusetts Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Incyte Corporation
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Dana-Farber Brigham and Womens Cancer Center at Milford Regional — Milford, Massachusetts (17.4 mi)
· Sponsor: Mirati Therapeutics Inc.